These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21538981)

  • 1. Use of multiple reaction monitoring for multiplex analysis of colorectal cancer-associated proteins in human feces.
    Ang CS; Rothacker J; Patsiouras H; Gibbs P; Burgess AW; Nice EC
    Electrophoresis; 2011 Aug; 32(15):1926-38. PubMed ID: 21538981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted in-gel MRM: a hypothesis driven approach for colorectal cancer biomarker discovery in human feces.
    Ang CS; Nice EC
    J Proteome Res; 2010 Sep; 9(9):4346-55. PubMed ID: 20684568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine fecal proteomics: a model system for the detection of potential biomarkers for colorectal cancer.
    Ang CS; Rothacker J; Patsiouras H; Burgess AW; Nice EC
    J Chromatogr A; 2010 May; 1217(19):3330-40. PubMed ID: 19875126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
    Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
    Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
    Zhao L; Liu Y; Sun X; Peng K; Ding Y
    J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
    Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stool test for colorectal cancer screening--it's time to move!
    Loitsch SM; Shastri Y; Stein J
    Clin Lab; 2008; 54(11-12):473-84. PubMed ID: 19216253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive testing for colorectal cancer: a review.
    Ouyang DL; Chen JJ; Getzenberg RH; Schoen RE
    Am J Gastroenterol; 2005 Jun; 100(6):1393-403. PubMed ID: 15929776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
    Barderas R; Babel I; Casal JI
    Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of colorectal cancer: discovering novel biomarkers.
    Skandarajah AR; Moritz RL; Tjandra JJ; Simpson RJ
    Expert Rev Proteomics; 2005 Oct; 2(5):681-92. PubMed ID: 16209648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry.
    Chen JS; Chen KT; Fan CW; Han CL; Chen YJ; Yu JS; Chang YS; Chien CW; Wu CP; Hung RP; Chan EC
    FEBS J; 2010 Jul; 277(14):3028-38. PubMed ID: 20546304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fecal oncomarkers in the diagnostics of colorectal cancer].
    Mikhań≠lova EI; Pimanov SI; Voropaev EV
    Klin Med (Mosk); 2007; 85(12):62-7. PubMed ID: 18318171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers for colorectal cancer through proteomics-based approaches.
    Tjalsma H
    Expert Rev Proteomics; 2010 Dec; 7(6):879-95. PubMed ID: 21142889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved fecal DNA test for colorectal cancer screening.
    Itzkowitz SH; Jandorf L; Brand R; Rabeneck L; Schroy PC; Sontag S; Johnson D; Skoletsky J; Durkee K; Markowitz S; Shuber A
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):111-7. PubMed ID: 17161655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
    Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
    J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.